Skip to main content
  • an Accelerating Medicines Partnership® (AMP®) program
Register Workbench

NEI Main Menu

  • Register Workbench
  • About
      • About AMP PD
      • AMP PD Use Cases
      • Contact Us
      • Glossary
      • Who we are
  • News & Updates
      • News & Updates
      • Release Updates
      • AMP PD Research Plan
      • News & Articles Archive
  • Data
      • Data
      • Harmonized Data
        • Summary Data Dashboard
        • Whole Genome Data
        • Transcriptomics Data
        • Targeted Proteomics Data
        • Clinical Assessment Data
      • Federated Data
        • GP2 Cohort Dashboard
        • Genomic Data
  • Cohorts
      • Cohorts
      • Unified Cohorts
        • BioFIND
        • HBS
        • LBD
        • LCC
        • PDBP
        • PPMI
        • STEADY-PD3
        • SURE-PD3
      • Federated Cohorts
        • GP2
  • Tools
      • Terra Platform
      • SmartConverter Data Curation
      • Visualization Tools & Resources
  • Researchers
      • Knowledge Platform Governance
      • Register for AMP PD
      • Data Use Agreement
  • Portal Resources
      • How To & References
      • AMP PD Webinar
      • Cloud Cost Guidelines
      • Cloud Architecture
      • Computing Guidelines
Register Workbench
  • Home
  • /
  • < Back To News & Updates
  • /
  • News and Articles Archive

News and Articles Archive

items out of 49

Multi-modality machine learning predicting Parkinson’s disease

April 1, 2022

Dennis et al 2021 medrxiv. Machine Learning Prediction of Parkinson’s Disease Onset and Subtype Using Germline Variants

June 14, 2021

Toffoli et al 2021 Movement Disorders. Intronic Haplotypes in the GBA Gene Do Not Predict Age at Diagnosis of Parkinson's Disease

May 19, 2021

Dong et al 2021 Briefings in Functional Genomics. Review of multi-omics data resources and integrative analysis for human brain disorders

May 8, 2021

Iwaki et al 2020 Movement Disorders. Accelerating Medicines Partnership: Parkinson’s Disease. Genetic Resource

May 7, 2021

Lake et al 2021 medrxiv. LRRK2 coding variants and the risk of Parkinson’s disease

April 23, 2021

Malpeli et al 2021 Hum Mol Genet. Identification of LRRK2 missense variants in the accelerating medicines partnership Parkinson's disease cohort

March 15, 2021

Moore 2021 medrxiv. A genetic and transcriptomic assessment of the KTN1 gene in Parkinson’s disease risk

March 12, 2021

Moore et al 2020 Neurobiology of Aging.. Assessment of ANG variants in Parkinson’s disease

March 9, 2021

19. Makarious 2020 medrxiv. Multi-Modality Machine Learning Predicting Parkinson’s Disease

March 7, 2021

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Next page Next
  • Last page Last
ACCELERATING MEDICINES PARTNERSHIP and AMP are registered service marks of the U.S. Department of Health and Human Services.

Footer Links

  • Contact us
  • Policy & Governance
  • Privacy Statement
  • Disclaimer
  • Site Map
  • Accessibility Policy
  • Reuse & Copyright
  • Glossary